Análisis de la cuota de mercado y oportunidades de los inhibidores de la neuraminidasa (2025-2031)
Neuraminidase Inhibitor Market Report Analysis
Neuraminidase Inhibitor Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Strides Consumer LLC
- BioCryst Pharmaceuticals, Inc
- Teva Pharmaceuticals Industries Ltd
- NATCO Pharma Limited
- Alvogen
- Amneal Pharmaceuticals LLC
- Macleods Pharmaceuticals Ltd
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline Plc
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
By Indicación
- Virus de la influenza A
- Virus de la influenza B
- otros
By Tipo de medicamento
- Zanamivir
- Oseltamivir
- Peramivir
- Laninamivir
- otros
By Vía de Administración
- Parenteral
- Oral
- Otras
By Canal de Distribución
- Farmacia Hospitalaria
- Farmacia Minorista
- Otros
Get Free Sample For